Ocean Biomedical (OCEA) Financial Statements
Ocean Biomedical Financial Overview
Ocean Biomedical's market cap is currently $69.71K. The company's EPS TTM is $-1.12; its P/E ratio is -0.00; Ocean Biomedical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -3.80M | $ -2.48M | $ -566.56K | $ -1.65M | $ -232.00K |
| EBITDA | $ -7.43M | $ -957.74K | $ -327.55K | $ -1.65M | $ -232.00K |
| Net Income | $ -3.30M | $ 565.47K | $ -62.34M | $ -1.65M | $ -232.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 224.00K | $ 328.31K | $ 1.08M | $ 0.00 | $ 0.00 |
| Total Assets | $ 902.00K | $ 110.91M | $ 108.65M | $ 386.00K | $ 0.00 |
| Total Debt | $ 16.30M | $ 2.15M | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 16.30M | $ 1.82M | $ -60.00K | $ 0.00 | $ 0.00 |
| Total Liabilities | $ 98.52M | $ 6.61M | $ 3.40M | $ 2.27M | $ 232.00K |
| Stockholders' Equity | $ -97.62M | $ 104.30M | $ 105.26M | $ -1.89M | $ -232.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -4.18M | $ -747.30K | $ -1.05M | $ -64.00K | $ 0.00 |
| Operating Cash Flow | $ -4.18M | $ -747.30K | $ -1.05M | $ -64.00K | $ 0.00 |
| Investing Cash Flow | $ 0.00 | $ -2.10M | $ -107.10M | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 3.40M | $ 2.10M | $ 1.11M | $ 64.00K | $ 0.00 |
Currency in USD
